12/6
08:06 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $21.00 price target on the stock.
Medium
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $21.00 price target on the stock.
11/11
11:42 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $27.00. They now have a "buy" rating on the stock.
Low
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $27.00. They now have a "buy" rating on the stock.
11/8
07:32 am
igms
IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M [Seeking Alpha]
Medium
Report
IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M [Seeking Alpha]
11/8
07:00 am
igms
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
11/7
06:58 am
igms
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Low
Report
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
11/7
02:19 am
igms
Medivir AB (OSTO:MVIR) Q3 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... [Yahoo! Finance]
Low
Report
Medivir AB (OSTO:MVIR) Q3 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... [Yahoo! Finance]
11/4
07:00 am
igms
IGM Biosciences to Present at Three Upcoming Investor Conferences
Medium
Report
IGM Biosciences to Present at Three Upcoming Investor Conferences
10/18
08:32 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Royal Bank of Canada from $17.00 to $20.00. They now have an "outperform" rating on the stock.
Low
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Royal Bank of Canada from $17.00 to $20.00. They now have an "outperform" rating on the stock.